Impel Pharmaceuticals has conducted clinical studies of investigational upper nasal therapies.
For more information, follow the links below to the study listings on clinicaltrials.gov.
PHASE 3 STUDY
INP104
Safety and Tolerability of POD-DHE (INP104) in Migraine (STOP-301)
STATUS: COMPLETED
PHASE 1 STUDY
INP104
Bioavailability of DHE Administered by I123 POD Device, IV Injection, and Migranal Nasal Spray in Healthy Adults
STATUS: COMPLETED
PHASE 2 STUDY
INP103
Therapeutic Potential for Intranasal Levodopa in Parkinson’s Disease -Off Reversal (THOR 201)
STATUS: COMPLETED
PHASE 1 STUDY
INP105
Safety and Tolerability of INP105 (Olanzapine by I231 POD® Device) Nasal Spray in Healthy Volunteers – SNAP 101
STATUS: COMPLETED